Procaps Group Sa Share Price Today
(NASDAQ: PROC)

Name: Procaps Group Sa Share Price Today (NASDAQ: PROC) - Procaps Group Sa Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Procaps Group Sa share price is $1.59 & ₹137.76 as on 1 Feb 2025, 2.30 'hrs' IST

$1.59

Market is closed - opens 8 PM, 03 Feb 2025

View live Procaps Group Sa share price in Dollar and Rupees. Guide to invest in Procaps Group Sa stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Procaps Group Sa, along with analyst recommendations, forecasts, and comprehensive financials.

Procaps Group Sa share price movements

Today's Low: $1.59
Today's High: $1.62
$1.59
0.0%
Downside
Day's Volatility :1.85%
Upside
1.85%
52 Weeks Low: $0.50
52 Weeks High: $3.84
$1.59
68.55%
Downside
52 Weeks Volatility :86.98%
Upside
58.59%

Procaps Group Sa (PROC) Returns

Period	Procaps Group Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.63%	-0.6%	0.0%
6 Months	-27.2%	-2.6%	0.0%
1 Year	-56.42%	3.4%	0.0%
3 Years	-83.36%	10.1%	-12.8%

Procaps Group Sa (PROC) Key Statistics

in dollars & INR

Previous Close	$1.59
Open	$1.62
Today's High	$1.62
Today's Low	$1.59
Market Capitalization	$179.4M
Today's Volume	$3.8K
52 Week High	$3.84
52 Week Low	$0.5
Revenue TTM	$414.1M
EBITDA	$57.1M
Earnings Per Share (EPS)	$0.51
PE Ratio	3.12
Profit Margin	12.61%
Quarterly Earnings Growth YOY	-0.64%
Return On Equity TTM	37.37%

How to invest in Procaps Group Sa Stock (PROC) from India?

It is very easy for Indian residents to invest directly in Procaps Group Sa from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Procaps Group Sa stock in both Indian Rupees (INR) and US Dollars (USD). Search for Procaps Group Sa or PROC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Procaps Group Sa or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Procaps Group Sa shares which would translate to 0.545 fractional shares of Procaps Group Sa as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Procaps Group Sa, in just a few clicks!

Returns in Procaps Group Sa (PROC) for Indian investors in Rupees

The Procaps Group Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Procaps Group Sa investment value today

Current value as on today

₹48,121

Returns

₹51,879

(-51.88%)

Returns from Procaps Group Sa Stock

₹56,438 (-56.44%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Procaps Group Sa (PROC)

-53%

Period: Jan 2, 2025 to Feb 1, 2025. Change in 30 Days versus previous period

Search interest for Procaps Group Sa Stock from India on INDmoney has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Procaps Group Sa

Exome Asset Management LLC
0.11%
Geode Capital Management, LLC
0.03%
Activest Wealth Management
0.01%

Analyst Recommendation on Procaps Group Sa

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Procaps Group Sa(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Procaps Group Sa Stock (PROC)

What analysts predicted

Upside of 214.47%

Target:

$5.00

Current:

$1.59

Insights on Procaps Group Sa Stock (Ticker Symbol: PROC)

Price Movement
In the last 1 month, PROC stock has moved down by -31.7%
Increasing Revenue
Revenue is up for the last 4 quarters, 101.46M → 118.41M (in $), with an average increase of 5.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 26.95M → 8.19M (in $), with an average decrease of 34.8% per quarter
PROC vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 89.0% return, outperforming this stock by 146.1%
PROC vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 164.4% return, outperforming this stock by 247.7%
Price to Sales
ForPROC every $1 of sales, investors are willing to pay $0.4, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.8 for every $1 of sales.

PROC Procaps Group Sa Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$324.8M	-
Net Income	$-17.0M	-
Net Profit Margin	-5.24%	-

	FY20	Y/Y Change
Revenue	$331.5M	↑ 2.06%
Net Income	$-10.4M	↓ 38.59%
Net Profit Margin	-3.15%	↑ 2.09%

	FY21	Y/Y Change
Revenue	$409.7M	↑ 23.61%
Net Income	$-100.9M	↑ 865.47%
Net Profit Margin	-24.62%	↓ 21.47%

	FY22	Y/Y Change
Revenue	$409.9M	↑ 0.04%
Net Income	$42.5M	↓ 142.18%
Net Profit Margin	10.38%	↑ 35.0%

	FY23	Y/Y Change
Revenue	$414.1M	↑ 1.02%
Net Income	$52.2M	↑ 22.72%
Net Profit Margin	12.61%	↑ 2.23%

	Q2 FY22	Q/Q Change
Revenue	$112.4M	↓ 11.16%
Net Income	$-6.9M	↓ 85.05%
Net Profit Margin	-6.15%	↑ 30.43%

	Q3 FY22	Q/Q Change
Revenue	$110.4M	↓ 1.79%
Net Income	$22.6M	↓ 426.35%
Net Profit Margin	20.45%	↑ 26.6%

	Q4 FY22	Q/Q Change
Revenue	$101.5M	↓ 8.09%
Net Income	$10.4M	↓ 53.79%
Net Profit Margin	10.28%	↓ 10.17%

	Q1 FY23	Q/Q Change
Revenue	$110.1M	↑ 8.47%
Net Income	$27.0M	↑ 158.34%
Net Profit Margin	24.49%	↑ 14.21%

	Q2 FY23	Q/Q Change
Revenue	$118.4M	↑ 7.59%
Net Income	$8.2M	↓ 69.6%
Net Profit Margin	6.92%	↓ 17.57%

	Q3 FY23	Q/Q Change
Revenue	$118.4M	↑ 0.0%
Net Income	$8.2M	↑ 0.0%
Net Profit Margin	6.92%	↑ 0.0%

	FY19	Y/Y Change
Profit	$182.5M	-

	FY20	Y/Y Change
Profit	$191.3M	↑ 4.83%

	FY21	Y/Y Change
Profit	$235.7M	↑ 23.21%

	FY22	Y/Y Change
Profit	$239.6M	↑ 1.64%

	FY23	Y/Y Change
Profit	$227.9M	↓ 4.87%

	Q2 FY22	Q/Q Change
Profit	$72.6M	↓ 4.0%

	Q3 FY22	Q/Q Change
Profit	$67.6M	↓ 6.99%

	Q4 FY22	Q/Q Change
Profit	$52.3M	↓ 22.65%

	Q1 FY23	Q/Q Change
Profit	$61.2M	↑ 17.1%

	Q2 FY23	Q/Q Change
Profit	$68.4M	↑ 11.79%

	Q3 FY23	Q/Q Change
Profit	$68.4M	↑ 0.0%

	FY19	Y/Y Change
Operating Cash Flow	$68.3M	-
Investing Cash Flow	$-12.1M	-
Financing Cash Flow	$-46.9M	-

	FY20	Y/Y Change
Operating Cash Flow	$70.9M	↑ 3.86%
Investing Cash Flow	$-17.1M	↑ 41.61%
Financing Cash Flow	$-40.5M	↓ 13.72%

	Q2 FY22	Q/Q Change
Operating Cash Flow	$10.0M	↓ 61.68%
Investing Cash Flow	$-8.9M	↑ 114.28%
Financing Cash Flow	$-26.0M	↓ 55.14%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$5.8M	↓ 42.21%
Investing Cash Flow	$-7.5M	↓ 16.3%
Financing Cash Flow	$-5.4M	↓ 79.41%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 238.01%
Investing Cash Flow	$-5.0M	↓ 32.62%
Financing Cash Flow	$27.9M	↓ 620.91%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$20.4M	↓ 357.18%
Investing Cash Flow	$-5.0M	↑ 0.0%
Financing Cash Flow	$-25.0M	↓ 189.59%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$47.4M	↑ 131.98%
Investing Cash Flow	$-7.9M	↑ 56.65%
Financing Cash Flow	$-29.9M	↑ 19.44%

Procaps Group Sa Technicals Summary

Sell

Neutral

Buy

Procaps Group Sa is currently in a neutral trading position according to technical analysis indicators.

Procaps Group Sa (PROC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procaps Group Sa	-29.3%	-27.2%	-56.42%	-83.36%	-84.4%
Intra-cellular Therapies, Inc.	51.79%	63.34%	84.17%	174.47%	476.59%
Haleon Plc Spon Ads	0.11%	-0.42%	13.41%	27.8%	27.8%
Zoetis Inc.	4.65%	-2.24%	-10.13%	-14.94%	22.98%
Neurocrine Biosciences Inc.	9.93%	2.79%	7.17%	90.85%	47.26%
Viatris Inc.	-8.14%	-2.42%	-2.59%	-25.45%	-30.97%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Procaps Group Sa	3.12	3.12	NA	0.0	0.37	0.06	NA	0.39
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.7	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	29.0	29.0	1.7	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	32.12	32.12	2.69	5.89	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	40.38	40.38	0.35	6.59	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procaps Group Sa	Buy	$179.4M	-84.4%	3.12	12.61%
Intra-cellular Therapies, Inc.	Buy	$13.5B	476.59%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$43.3B	27.8%	29.0	10.75%
Zoetis Inc.	Buy	$77.1B	22.98%	32.12	26.55%
Neurocrine Biosciences Inc.	Buy	$15.4B	47.26%	40.38	17.21%
Viatris Inc.	Hold	$13.5B	-30.97%	224.4	-5.87%

About Procaps Group Sa

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

Organization	Procaps Group Sa
Employees	5500
CEO	Mr. Jose Antonio Toledo Vieira
Industry	Financial

Management People of Procaps Group Sa

Name	Title
Mr. Jose Antonio Toledo Vieira	Chief Executive Officer
Mr. Daniel Bernal	Interim Chief Financial Officer
Dr. Camilo Camacho	Chief Operations Officer
Ms. Melissa Angelini	Interim VP of Finance & Investor Relations Director
Ms. Marcela Carvajalino Pagano	Vice-President of Corporate & Legal Affairs
Mr. Luis Alberto Palacios Aragon	Vice-President of International Marketing and R&D
Mr. Mauricio Castaneda Caballero	Vice-President of Human Resources
Mr. Patricio Vargas Munoz	Chief Optimization and Rationalization Officer

Important FAQs about investing in PROC Stock from India :

What is Procaps Group Sa share price today?

Procaps Group Sa share price today stands at $1.59, Open: $1.62 ; Previous Close: $1.59 ; High: $1.62 ; Low: $1.59 ; 52 Week High: $3.84 ; 52 Week Low: $0.50.

The stock opens at $1.62, after a previous close of $1.59. The stock reached a daily high of $1.62 and a low of $1.59, with a 52-week high of $3.84 and a 52-week low of $0.50.

Can Indians buy Procaps Group Sa shares?

Yes, Indians can invest in the Procaps Group Sa (PROC) from India.

With INDmoney, you can buy Procaps Group Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Procaps Group Sa at zero transaction cost.

How can I buy Procaps Group Sa shares from India?

It is very easy to buy Procaps Group Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Procaps Group Sa (PROC) be purchased?

Yes, you can buy fractional shares of Procaps Group Sa with INDmoney app.

What are the documents required to start investing in Procaps Group Sa stocks?

To start investing in Procaps Group Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.